Assembly Biosciences, Inc.
ASMB
Revenue
3.89M
▼-400.85k▼-9.35%
6 Months ChangeAssets
115.32M
▼-4.56M▼-3.80%
3 Months ChangeLiabilities
80.64M
▼-6.64M▼-7.61%
3 Months ChangeFree Cash Flow
-18.38M
▲5.05M▲21.56%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-23
Form 8-K
ID: 0000950170-24-108629
2024-08-08
Form 10-Q
ID: 0000950170-24-093998
2024-08-08
Form 8-K
ID: 0000950170-24-093946
2024-06-18
Form 8-K
ID: 0001193125-24-163398
2024-06-03
Form 8-K
ID: 0000950170-24-067951
2024-05-08
Form 10-Q
ID: 0000950170-24-055680
2024-05-08
Form 8-K
ID: 0000950170-24-055650
2024-03-28
Form 8-K
ID: 0000950170-24-038044
2024-03-15
Form 8-K
ID: 0000950170-24-032162
2024-02-13
Form 8-K
ID: 0000950170-24-014534